Race or genetic makeup for hepatitis C virus treatment decisions?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Race or genetic makeup for hepatitis C virus treatment decisions?

Published:2017-04-18 Issue:6 Volume:65 Page:2124-2125
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

O'Brien Thomas R.¹,Kottilil Shyam²,Feld Jordan J.³,Morgan Timothy R.⁴,Pfeiffer Ruth M.⁵

Affiliation:

1. Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics; National Cancer Institute; Bethesda MD

2. Division of Clinical Care and Research, Institute of Human Virology; University of Maryland School of Medicine; Baltimore MD

3. Toronto Centre for Liver Disease; University of Toronto; Toronto Canada

4. VA Long Beach Healthcare System; Long Beach CA

5. Biostatistics Branch, Division of Cancer Epidemiology and Genetics; National Cancer Institute; Bethesda MD

Funder

National Institutes of Health

Publisher

Wiley

Subject

Hepatology

Reference5 articles.

1. The association between race/ethnicity and the effectiveness of direct antiviral agents for hepatitis C virus infection;Su;Hepatology,2017

2. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus;Prokunina-Olsson;Nat Genet,2013

3. O'Brien TR Lang Kuhs KA Pfeiffer RM Subgroup differences in response to 8 weeks of ledipasvir/sofosbuvir for chronic hepatitis C 2014 1 https://doi.org/10.1093/ofid/ofu110

4. Ledipasvir and sofosbuvir for HCV in patients coinfected with HIV-1;Naggie;N Engl J Med,2015

5. Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: an integrated safety and efficacy analysis;Reddy;Hepatology,2015

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IFNL4 genotype and other personal characteristics to predict response to 8-week sofosbuvir-based treatment for chronic hepatitis C;Journal of Infection;2024-11

2. In search of a function for human type III interferons: insights from inherited and acquired deficits;Current Opinion in Immunology;2024-04

3. Utility of a buccal swab point-of-care test for the IFNL4 genotype in the era of direct acting antivirals for hepatitis C virus;PLOS ONE;2023-01-23

4. Interleukin 28B Polymorphism as a Predictor of Sustained Virological Response to Sofosbuvir-Based Therapy for Hepatitis C Virus Patients;Tropical Medicine and Infectious Disease;2022-09-05

5. The Knowledge on HCV: From the Discovery to the Elimination;Infectious Microbes and Diseases;2022-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3